Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors
- 1 December 2005
- journal article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 201 (12) , 771-776
- https://doi.org/10.1016/j.prp.2005.08.010
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lymphatic vasculature developmentNature Reviews Immunology, 2004
- Lymphangiogenic growth factors, receptors and therapiesThrombosis and Haemostasis, 2003
- Molecular mechanisms of lymphangiogenesis in health and diseaseCancer Cell, 2002
- Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of AngiosarcomasLaboratory Investigation, 2002
- Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3The EMBO Journal, 2001
- LYVE-1, the lymphatic system and tumor lymphangiogenesisTrends in Immunology, 2001
- Epidemiology and pathogenesis of Kaposi's sarcoma–associated herpesvirusPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of AngiosarcomasLaboratory Investigation, 2000
- Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic CapillariesThe American Journal of Pathology, 1999